The topic and treatment of contagious disease has become controversial since COVID-19 came along, but what is not ...

Goldman Sachs analyst Salveen Richter downgraded Moderna (NASDAQ:MRNA) stock from Buy to Neutral, significantly reducing the price target to $51 from the previous $99. Trading at $44.94, the stock has ...

"Zero evidence that the flu shot prevents any hospitalizations or any deaths ... If you get a flu shot you're six times more ...

Food Standards Scotland (FSS) is to develop guidance for sellers of food on social media after a survey found buying products in this way was more common than predicted. Research focused on ready ...